-
Document de presse | 2023.11.14
Significant "post-COVID" resurgence in invasive meningococcal disease
A team of scientists from the Institut Pasteur has used the database of the National Reference Center for Meningococci to trace the evolution of invasive meningococcal disease cases in France between 2015 and 2022, revealing an unprecedented resurgence in the disease after the easing of control measures imposed during the COVID-19 epidemic. Recently reported cases have mainly been caused by...
-
News | 2024.07.04
How coronavirus HKU1 forces its way into cells
Scientists have pinpointed the precise binding sites for the virus HKU1 in respiratory cells, providing a detailed picture of the infection mechanism used by the virus. Their findings shed light on other animal species that may host the virus and pave the way for the development of infection-blocking antibodies.
-
Article | 2023.12.18
Interdisciplinary Training in Genomic Epidemiology and Public Health Bioinformatics
This interdisciplinary programme, funded by ECDC, combines lectures and practical sessions delivered by multiple host institutions in order to enhance surveillance, preparedness, and readiness to respond to outbreaks.
-
News | 2026.02.12
Hepatitis B: two major breakthroughs raise hopes of eradicating chronic illness
Current treatments for hepatitis B do not cure the disease and often have to be taken for life. Two recent breakthroughs in the Institut Pasteur's research offer real hopes of progress for patients, at a time when 250 million people worldwide are living with chronic hepatitis B virus infection.
-
Document de presse | 2014.01.23
A new bacterial mechanism for evading the immune system
A team of scientists from the Institut Pasteur, the CNRS and Paris Diderot University has identified a new regulation mechanism that enables a pathogenic bacterium of the Streptococcus genus to rapidly adapt to its host. This study was published on January 16, 2014 in PLoS Pathogens. The mechanism in question enables the bacterium to minimize its exposure to the immune system while maintaining...
-
Document de presse | 2013.04.16
Legionellosis: unique host cell reprogramming induced by the bacterial pathogen Legionella pneumophila
Scientists at the Institut Pasteur, the CNRS, the Institut Curie and Inserm have identified a unique mechanism that enables the bacterial pathogen Legionella pneumophila (the causative agent of Legionnaires’ disease or legionellosis) to "reprogram" the gene expression of the eukaryotic cells that it infects. This mechanism, which has never been observed before, facilitates the...
-
Document de presse | 2012.10.31
New Finding Helps Explain Antibiotic Resistance in Staphylococcus aureus
Researchers at the Institut Pasteur, the CNRS, and the University of Tsukuba Faculty of Medicine (Japan) have proven for the first time that activating a specific gene in Staphylococcus aureus enables it to incorporate extracellular DNA and develop resistance to methicillin. They have also identified two mechanisms for the activation of the gene in question. These results represent an important...
-
Document de presse | 2012.09.26
Malaria Takes a Hit – Two New Molecules Stop P. falciparum in its Tracks
Researchers at the Institut Pasteur and the French National Center for Scientific Research (CNRS), in collaboration with Imperial College London, have synthesized two molecules capable of quickly and irreversibly stopping the growth of P. falciparum at every blood stage of its life cycle. These molecules work by inhibiting the histone methyltransferase enzymes necessary for the parasite’s...
-
Document de presse | 2012.02.23
New cancer target identified?
A team of researchers from the Institut Pasteur and the CNRS has recently identified a protein that can specifically control the activity of an enzyme whose dysfunction has been linked to the development of several types of cancer. This work reveals a potential therapeutic target for the treatment of certain tumors. This study is being published today in the scientific journal Molecular Cell....
-
Document de presse | 2011.03.06
Powerful human DNA mutators identified
Scientists from the Institut Pasteur, the French National Center for Scientific Research (CNRS), and the French National Institute for Health and Medical Research (Inserm) have shown that a cellular protein, APOBEC3A, known for its antiviral activity, is also capable of mutagenic activity on human cell DNA. This discovery suggests that this protein plays a role in the cellular DNA degradation...